50 related articles for article (PubMed ID: 11019835)
1. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma.
Stiff P; Gingrich R; Luger S; Wyres MR; Brown RA; LeMaistre CF; Perry J; Schenkein DP; List A; Mason JR; Bensinger W; Wheeler C; Freter C; Parker WRL ; Emmanouilides C
Bone Marrow Transplant; 2000 Sep; 26(5):471-81. PubMed ID: 11019835
[TBL] [Abstract][Full Text] [Related]
2. Prediction of mobilized hematopoietic stem cell yield in patients with multiple myeloma: Usefulness of whole-body MRI-derived indices.
Takasu M; Higashino R; Sueoka T; Kawai S; Tanitame N; Tamura A; Iida M; Kawase T; Ichinohe T; Awai K
PLoS One; 2023; 18(3):e0283241. PubMed ID: 37000837
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials.
Luo C; Wu G; Huang X; Zhang Y; Ma Y; Huang Y; Huang Z; Li H; Hou Y; Chen J; Li X; Xu S
Stem Cell Res Ther; 2022 Mar; 13(1):123. PubMed ID: 35317856
[TBL] [Abstract][Full Text] [Related]
4. GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma.
Crees ZD; Stockerl-Goldstein K; Vainstein A; Chen H; DiPersio JF
Future Oncol; 2019 Nov; 15(31):3555-3563. PubMed ID: 31495201
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma.
Ri M; Matsue K; Sunami K; Shimazaki C; Hayashi A; Sunaga Y; Sasaki T; Suzuki K
Int J Hematol; 2017 Oct; 106(4):562-572. PubMed ID: 28527129
[TBL] [Abstract][Full Text] [Related]
6. New agents in HSC mobilization.
Domingues MJ; Nilsson SK; Cao B
Int J Hematol; 2017 Feb; 105(2):141-152. PubMed ID: 27905003
[TBL] [Abstract][Full Text] [Related]
7. Advances in stem cell mobilization.
Hopman RK; DiPersio JF
Blood Rev; 2014 Jan; 28(1):31-40. PubMed ID: 24476957
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell mobilization for gene therapy: superior mobilization by the combination of granulocyte-colony stimulating factor plus plerixafor in patients with β-thalassemia major.
Yannaki E; Karponi G; Zervou F; Constantinou V; Bouinta A; Tachynopoulou V; Kotta K; Jonlin E; Papayannopoulou T; Anagnostopoulos A; Stamatoyannopoulos G
Hum Gene Ther; 2013 Oct; 24(10):852-60. PubMed ID: 24001178
[TBL] [Abstract][Full Text] [Related]
9. The combination of stem cell factor and granulocyte-colony stimulating factor for chronic stroke treatment in aged animals.
Piao CS; Gonzalez-Toledo ME; Gu X; Zhao LR
Exp Transl Stroke Med; 2012 Dec; 4(1):25. PubMed ID: 23254113
[TBL] [Abstract][Full Text] [Related]
10. The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke.
Zhao LR; Piao CS; Murikinati SR; Gonzalez-Toledo ME
Recent Pat CNS Drug Discov; 2013 Apr; 8(1):2-12. PubMed ID: 23173646
[TBL] [Abstract][Full Text] [Related]
11. The plasminogen system in regulating stem cell mobilization.
Gong Y; Hoover-Plow J
J Biomed Biotechnol; 2012; 2012():437920. PubMed ID: 23118508
[TBL] [Abstract][Full Text] [Related]
12. Challenges for heart disease stem cell therapy.
Hoover-Plow J; Gong Y
Vasc Health Risk Manag; 2012; 8():99-113. PubMed ID: 22399855
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen regulates stromal cell-derived factor-1/CXCR4-mediated hematopoietic stem cell mobilization by activation of matrix metalloproteinase-9.
Gong Y; Fan Y; Hoover-Plow J
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2035-43. PubMed ID: 21719761
[TBL] [Abstract][Full Text] [Related]
14. Targeting stem cell niches and trafficking for cardiovascular therapy.
Kränkel N; Spinetti G; Amadesi S; Madeddu P
Pharmacol Ther; 2011 Jan; 129(1):62-81. PubMed ID: 20965213
[TBL] [Abstract][Full Text] [Related]
15. Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes.
Lee HM; Wysoczynski M; Liu R; Shin DM; Kucia M; Botto M; Ratajczak J; Ratajczak MZ
Leukemia; 2010 Mar; 24(3):573-82. PubMed ID: 20033053
[TBL] [Abstract][Full Text] [Related]
16. Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications.
Hombach-Klonisch S; Panigrahi S; Rashedi I; Seifert A; Alberti E; Pocar P; Kurpisz M; Schulze-Osthoff K; Mackiewicz A; Los M
J Mol Med (Berl); 2008 Dec; 86(12):1301-14. PubMed ID: 18629466
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand.
Pelus LM
Curr Opin Hematol; 2008 Jul; 15(4):285-92. PubMed ID: 18536564
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic growth factors pass through the blood-brain barrier in intact rats.
Zhao LR; Navalitloha Y; Singhal S; Mehta J; Piao CS; Guo WP; Kessler JA; Groothuis DR
Exp Neurol; 2007 Apr; 204(2):569-73. PubMed ID: 17307165
[TBL] [Abstract][Full Text] [Related]
19. Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.
Quittet P; Ceballos P; Lopez E; Lu ZY; Latry P; Becht C; Legouffe E; Fegueux N; Exbrayat C; Pouessel D; Rouillé V; Daures JP; Klein B; Rossi JF
Bone Marrow Transplant; 2006 Aug; 38(4):275-84. PubMed ID: 16883311
[TBL] [Abstract][Full Text] [Related]
20. Treatment of aggressive non-Hodgkin's lymphoma with chemotherapy in combination with filgrastim.
Schriber J
Drugs; 2002; 62 Suppl 1():33-46. PubMed ID: 12479593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
